Figure 1

Increased levels of specific autoAbs were observed in MMD patients compared to healthy controls by protein array. Targets included (A) calcium/calmodulin-dependent protein kinase II alpha (CAMK2A); (B) B-cell antigen receptor complex-associated protein alpha-chain (CD79A); (C) G protein pathway suppressor 1 (GPS1); (D) ephrin-A3 (EFNA3); (E) Na+/K + transporting ATPase interacting 4 (NKAIN4); (F) Transmembrane Protein 32 (TMEM32). RFU = relative fluorescence units.